- Lobbying
- Lobbying by Roche Diagnostics Corporation
Lobbying Relationship
Bills mentioned
H.R.3271: Protecting Access to Diabetes Supplies Act of 2017
Sponsor: Diana DeGette (D-Colo.)
S.1914: Protecting Access to Diabetes Supplies Act of 2017
Sponsor: Mark Warner (D-Va.)
H.R.771: Protecting Access to Diabetes Supplies Act of 2015
Sponsor: Diana DeGette (D-Colo.)
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
H.R.1726: Access to Quality Diabetes Education Act of 2015
Sponsor: Edward Whitfield (R-Ky.)
S.1101: MEDTECH Act
Sponsor: Michael Bennet (D-Colo.)
S.232: Medical Device Access and Innovation Protection Act
Sponsor: Orrin G. Hatch (R-Utah)
H.R.523: Protect Medical Innovation Act of 2013
Sponsor: Erik Paulsen (R-Minn.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Lisa Layman | CBO, PA(92-96); LA, Sen Chafee(97-99); LA, Sen Bryan(00); SPA, Sen Graham(01-04); SPA, Sen Stabenow(05-07) SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) SPA, Sen. Stabenow (05-07) |
Henry Menn III | CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995) Sp Asst Leg Aff, FDA Off of Commiss(93-95); CoS, Sen Bob Graham(01-04); Min SD & Counsel, Cmte on Vet Affairs (04) CoS, Sen. Bob Graham (01 - 04) |
ROBERT FOREMAN | The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 - 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 - 2005) |
Christopher Bowlin | Hlth & Dom Policy Adv, Sen McCain, 09-Aug 13; Dep Asst Secr for Legisl, HHS, 08-09 Dep Asst Secr for Congr & Intgv Affairs, Dept. Labor 01-02 Prof Staff, House Cmte on Ed & Workforce 99-01 |
Henry W Menn III | Sp Asst Leg Aff, FDA Off of Commiss(93-95); CoS, Sen Bob Graham(01-04); Min SD & Counsel, Cmte on Vet Affairs (04) |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate